118 related articles for article (PubMed ID: 10030472)
1. Use of risperidone and olanzapine in outpatient clinics at six Veterans Affairs hospitals.
Voris JC; Glazer WM
Psychiatr Serv; 1999 Feb; 50(2):163-4, 168. PubMed ID: 10030472
[No Abstract] [Full Text] [Related]
2. A retrospective economic evaluation of olanzapine versus risperidone in the treatment of schizophrenia.
Zhao Z
Manag Care Interface; 2002 Feb; 15(2):75-81. PubMed ID: 11875967
[TBL] [Abstract][Full Text] [Related]
3. Use of atypical antipsychotics in a Veterans Affairs hospital.
Schwartz TL; Saba M; Hardoby W; Virk S; Masand PS
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1207-10. PubMed ID: 12452548
[TBL] [Abstract][Full Text] [Related]
4. Cost evaluation of risperidone compared with olanzapine.
Byerly MJ; Weber M; Brooks D; Casey SB; Elliot S; Hawkins J
Psychiatr Serv; 2003 May; 54(5):742-4. PubMed ID: 12719509
[TBL] [Abstract][Full Text] [Related]
5. The effect of institutional fiscal stress on the use of atypical antipsychotic medications in the treatment of schizophrenia.
Leslie DL; Rosenheck R
J Nerv Ment Dis; 2001 Jun; 189(6):377-83. PubMed ID: 11434638
[TBL] [Abstract][Full Text] [Related]
6. Service use and costs among VA patients with schizophrenia taking risperidone or olanzapine.
Fuller MA; Shermock KM; Secic M; Laich JS; Durkin MB
Psychiatr Serv; 2002 Jul; 53(7):855-60. PubMed ID: 12096169
[TBL] [Abstract][Full Text] [Related]
7. [RODOS: risperidone olanzapine drug outcome studies in schizophrenia].
De Beauchamp I; Giraud-Baro E; Gury C
Encephale; 2002; 28 Spec No 2 Pt 2():S33-4. PubMed ID: 12587356
[No Abstract] [Full Text] [Related]
8. Epidemic of schizophrenia in children or inappropriate prescribing?
Jureidini JN
Med J Aust; 2000 Nov; 173(10):555-6. PubMed ID: 11194744
[No Abstract] [Full Text] [Related]
9. Olanzapine and risperidone.
Love RC; Kelly DL
Am J Health Syst Pharm; 2003 Mar; 60(5):487-8; author reply 488-9. PubMed ID: 12635459
[No Abstract] [Full Text] [Related]
10. Economic evaluations of olanzapine and risperidone.
Shaw JW
Am J Health Syst Pharm; 2002 Jul; 59(14):1366-75. PubMed ID: 12132564
[No Abstract] [Full Text] [Related]
11. Comparison of cost, dosage and clinical preference for risperidone and olanzapine.
Rabinowitz J; Lichtenberg P; Kaplan Z
Schizophr Res; 2000 Dec; 46(2-3):91-6. PubMed ID: 11120420
[TBL] [Abstract][Full Text] [Related]
12. Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine.
Kelly DL; Nelson MW; Love RC; Yu Y; Conley RR
Psychiatr Serv; 2001 May; 52(5):676-8. PubMed ID: 11331805
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine versus risperidone in the treatment of schizophrenia : a comparison of costs among Texas Medicaid recipients.
Rascati KL; Johnsrud MT; Crismon ML; Lage MJ; Barber BL
Pharmacoeconomics; 2003; 21(10):683-97. PubMed ID: 12828491
[TBL] [Abstract][Full Text] [Related]
14. Inpatient length of stay and atypical antipsychotic use among elderly patients with psychiatric disorders and Alzheimer's disease.
Edell WS; Rupnow MF
Manag Care Interface; 2003 May; 16(5):64-7. PubMed ID: 12789866
[TBL] [Abstract][Full Text] [Related]
15. Drug utilization patterns and outcomes associated with in-hospital treatment with risperidone or olanzapine.
Procyshyn RM; Zerjav S
Clin Ther; 1998; 20(6):1203-17; discussion 1192-3. PubMed ID: 9916613
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of risperidone, olanzapine, and conventional antipsychotic medications.
Jerrell JM
Schizophr Bull; 2002; 28(4):589-605. PubMed ID: 12795493
[TBL] [Abstract][Full Text] [Related]
17. New antipsychotic drugs produce better outcomes.
Healthc Benchmarks; 1997 Oct; 4(10):142-4. PubMed ID: 10173374
[No Abstract] [Full Text] [Related]
18. Influence of patient co-payments on atypical antipsychotic choice in Poland: implications once generic atypicals are available.
Wladysiuk M; Araszkiewicz A; Godman B; Szabert K; Barbui C; Haycox A
Appl Health Econ Health Policy; 2011 Mar; 9(2):101-10. PubMed ID: 21271749
[TBL] [Abstract][Full Text] [Related]
19. Novel antipsychotic medications in the treatment of children and adolescents.
Malone RP; Sheikh R; Zito JM
Psychiatr Serv; 1999 Feb; 50(2):171-4. PubMed ID: 10030474
[No Abstract] [Full Text] [Related]
20. Evaluation of health services use following the initiation of risperidone long-acting therapy among schizophrenia patients in the veterans health administration.
Ren XS; Crivera C; Sikirica M; Dirani R; Qian S; Kazis LE
J Clin Pharm Ther; 2011 Jun; 36(3):383-9. PubMed ID: 21062329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
